Thymosin beta 4 ophthalmic solution for dry eye: a randomized, placebo-controlled, Phase II clinical trial conducted using the controlled adverse environment (CAE™) model
Gabriel Sosne,1 George W Ousler2 1Kresge Eye Institute, Wayne State University, Detroit, MI, 2Ora Inc, Andover, MA, USA Background: The purpose of this study was to evaluate the safety and efficacy of thymosin beta 4 ophthalmic solution (RGN-259; Tβ4) in subjects with moderate to severe d...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Dove Medical Press
2015
|
| Subjects: | |
| Online Access: | https://doaj.org/article/fa4fb8326fdf4bdea4232f6fd68330d2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|